MSB 2.58% 94.5¢ mesoblast limited

Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain, page-132

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.